CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 113 enrolled
Drug / intervention
IPGdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02976181
NCT02976181N/ACompleted
CompareCT.gov

Registry to Improve the Adoption of Consensus Treatment Guideline (Brady MX)

Medtronic Cardiac Rhythm and Heart Failure·observational·Posted Nov 29, 2016·Updated Sep 19, 2019

In Brief

An observational study evaluating IPG for Sinus Node Disfunction. Completed, enrolled 113 participants across 5 sites.

Detailed Summary

Medtronic is sponsoring a quality improvement study called Brady MX. It is hypothesized that lack of awareness of treatment and diagnostics pathways result in lower number of referrals to implanters of IPG.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSinus Node Disfunction
CountriesMexico
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 29, 2016
Enrollment StartDec 1, 2016
Primary CompletionJun 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.6 years ago

Interventions

IPGdevice

Patient might require IPG device to be implanted under standard of care